Glenmede Trust CO Na Deciphera Pharmaceuticals, Inc. Transaction History

Glenmede Trust CO Na

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $267,436 - $391,799	-8,171 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$40.39 - $56.73 $4,725 - $6,637	117 Added 1.45%	8,171 $366,000
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $42,192 - $53,936	815 Added 11.26%	8,054 $459,000
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $79,497 - $105,560	1,815 Added 33.46%	7,239 $371,000
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $43,533 - $76,410	1,175 Added 27.65%	5,424 $323,000
Q4 2019 Feb 12, 2020	BUY	$31.7 - $69.93 $6,308 - $13,916	199 Added 4.91%	4,249 $264,000
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $80,797 - $157,342	4,050 New	4,050 $137,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.